Cancer-associated Fibroblasts Promote an Immunosuppressive Microenvironment Through the Induction and Accumulation of Protumoral Macrophages

Overview

Journal Oncotarget

Specialty Oncology

Date 2017 Jan 5

PMID 28052009

Citations 136

Authors

Hideyuki Takahashi

Koichi Sakakura

Takeshi Kudo

Minoru Toyoda

Kyoichi Kaira

Tetsunari Oyama

Kazuaki Chikamatsu

Affiliations

Soon will be listed here.

Abstract

Stromal cells in the tumor microenvironment (TME) closely interact with tumor cells and affect tumor cell behavior in diverse manners. We herein investigated the mechanisms by which cancer-associated fibroblasts (CAFs) affect the functional polarization of tumor-associated macrophages (TAMs) in oral squamous cell carcinoma (OSCC) in vitro and in human cancer samples. The expression of CD68, CD14, CD163, CD200R, CD206, HLA-G, CD80, and CD86 was higher in CD14-positive cells co-cultured with the culture supernatants of CAFs established from OSCC specimens (CAF-educated cells) than in control cells. The gene expression level of ARG1, IL10, and TGFB1 was increased in CAF-educated cells. CAF-educated cells suppressed T cell proliferation more strongly than control cells, and the neutralization of TGF-β IL-10, or arginase I significantly restored T cell proliferation. We then investigated the relationship between the infiltration of CAFs and TAMs using tissue samples obtained from patients with OSCC. The infiltration of CAFs was associated with the numbers of CD68-positive and CD163-positive macrophages. It also correlated with lymphatic invasion, vascular invasion, lymph node involvement, and the TNM stage. The infiltration of CAFs was identified as an independent prognostic factor in OSCC. Our results indicate that CAFs play important roles in shaping the tumor immunosuppressive microenvironment in OSCC by inducing the protumoral phenotype of TAMs. Therapeutic strategies to reverse CAF-mediated immunosuppression need to be considered.

Citing Articles

Stratification of the immunotypes of tongue squamous cell carcinoma to improve prognosis and the response to immune checkpoint inhibitors.

Su Y, Ouchi R, Daroonpan P, Hamagaki M, Ikeda T, Rika N Cancer Immunol Immunother. 2025; 74(4):130.

PMID: 40025278 PMC: 11872838. DOI: 10.1007/s00262-025-03982-9.

4-1BB agonist targeted to fibroblast activation protein α synergizes with radiotherapy to treat murine breast tumor models.

Garate-Soraluze E, Serrano-Mendioroz I, Fernandez-Rubio L, de Andrea C, Barrio-Alonso C, Herrero C J Immunother Cancer. 2025; 13(2).

PMID: 39933836 PMC: 11815443. DOI: 10.1136/jitc-2024-009852.

Micro Immune Response On-chip (MIRO) models the tumour-stroma interface for immunotherapy testing.

Perucca A, Llonin A, Benach O, Hallopeau C, Rivas E, Linares J Nat Commun. 2025; 16(1):1279.

PMID: 39900918 PMC: 11790944. DOI: 10.1038/s41467-025-56275-1.

Development of FAP-targeted theranostics discovered by next-generation sequencing-augmented mining of a novel immunized VNAR library.

Gunaratne G, Gallant J, Ott K, Broome P, Celada S, West J bioRxiv. 2025; .

PMID: 39868181 PMC: 11761682. DOI: 10.1101/2025.01.13.632555.

Blood immunophenotyping of multiple sclerosis patients at diagnosis identifies a classical monocyte subset associated to disease evolution.

Rodriguez S, Couloume L, Ferrant J, Vince N, Mandon M, Jean R Front Immunol. 2025; 15():1494842.

PMID: 39845960 PMC: 11751469. DOI: 10.3389/fimmu.2024.1494842.

References

Fujii N, Shomori K, Shiomi T, Nakabayashi M, Takeda C, Ryoke K . Cancer-associated fibroblasts and CD163-positive macrophages in oral squamous cell carcinoma: their clinicopathological and prognostic significance. J Oral Pathol Med. 2012; 41(6):444-51. DOI: 10.1111/j.1600-0714.2012.01127.x. View

Gocheva V, Wang H, Gadea B, Shree T, Hunter K, Garfall A . IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. Genes Dev. 2010; 24(3):241-55. PMC: 2811826. DOI: 10.1101/gad.1874010. View

Paunescu V, Bojin F, Tatu C, Gavriliuc O, Rosca A, Gruia A . Tumour-associated fibroblasts and mesenchymal stem cells: more similarities than differences. J Cell Mol Med. 2010; 15(3):635-46. PMC: 3922385. DOI: 10.1111/j.1582-4934.2010.01044.x. View

Franco O, Shaw A, Strand D, Hayward S . Cancer associated fibroblasts in cancer pathogenesis. Semin Cell Dev Biol. 2009; 21(1):33-9. PMC: 2823834. DOI: 10.1016/j.semcdb.2009.10.010. View

Boire A, Covic L, Agarwal A, Jacques S, Sherifi S, Kuliopulos A . PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell. 2005; 120(3):303-13. DOI: 10.1016/j.cell.2004.12.018. View

Wyckoff J, Wang Y, Lin E, Li J, Goswami S, Stanley E . Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res. 2007; 67(6):2649-56. DOI: 10.1158/0008-5472.CAN-06-1823. View

Buck A, Schirrmeister H, Guhlmann C, Diederichs C, Shen C, Buchmann I . Ki-67 immunostaining in pancreatic cancer and chronic active pancreatitis: does in vivo FDG uptake correlate with proliferative activity?. J Nucl Med. 2001; 42(5):721-5. View

Daly A, McIlreavey L, Irwin C . Regulation of HGF and SDF-1 expression by oral fibroblasts--implications for invasion of oral cancer. Oral Oncol. 2007; 44(7):646-51. DOI: 10.1016/j.oraloncology.2007.08.012. View

Leef G, Thomas S . Molecular communication between tumor-associated fibroblasts and head and neck squamous cell carcinoma. Oral Oncol. 2013; 49(5):381-6. PMC: 3615086. DOI: 10.1016/j.oraloncology.2012.12.014. View

10.

Kellermann M, Sobral L, da Silva S, Zecchin K, Graner E, Lopes M . Mutual paracrine effects of oral squamous cell carcinoma cells and normal oral fibroblasts: induction of fibroblast to myofibroblast transdifferentiation and modulation of tumor cell proliferation. Oral Oncol. 2007; 44(5):509-17. DOI: 10.1016/j.oraloncology.2007.07.001. View

11.

Kalluri R, Zeisberg M . Fibroblasts in cancer. Nat Rev Cancer. 2006; 6(5):392-401. DOI: 10.1038/nrc1877. View

12.

Noy R, Pollard J . Tumor-associated macrophages: from mechanisms to therapy. Immunity. 2014; 41(1):49-61. PMC: 4137410. DOI: 10.1016/j.immuni.2014.06.010. View

13.

de Wever O, Mareel M . Role of tissue stroma in cancer cell invasion. J Pathol. 2003; 200(4):429-47. DOI: 10.1002/path.1398. View

14.

Schreiber R, Old L, Smyth M . Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science. 2011; 331(6024):1565-70. DOI: 10.1126/science.1203486. View

15.

Balsamo M, Scordamaglia F, Pietra G, Manzini C, Cantoni C, Boitano M . Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity. Proc Natl Acad Sci U S A. 2009; 106(49):20847-52. PMC: 2791633. DOI: 10.1073/pnas.0906481106. View

16.

Dudas J, Bitsche M, Schartinger V, Falkeis C, Sprinzl G, Riechelmann H . Fibroblasts produce brain-derived neurotrophic factor and induce mesenchymal transition of oral tumor cells. Oral Oncol. 2010; 47(2):98-103. PMC: 3042593. DOI: 10.1016/j.oraloncology.2010.11.002. View

17.

Jung D, Che Z, Kim J, Kim K, Kim K, Williams D . Tumor-stromal crosstalk in invasion of oral squamous cell carcinoma: a pivotal role of CCL7. Int J Cancer. 2009; 127(2):332-44. DOI: 10.1002/ijc.25060. View

18.

Takahashi H, Sakakura K, Kawabata-Iwakawa R, Rokudai S, Toyoda M, Nishiyama M . Immunosuppressive activity of cancer-associated fibroblasts in head and neck squamous cell carcinoma. Cancer Immunol Immunother. 2015; 64(11):1407-17. PMC: 11029788. DOI: 10.1007/s00262-015-1742-0. View

19.

Turley S, Cremasco V, Astarita J . Immunological hallmarks of stromal cells in the tumour microenvironment. Nat Rev Immunol. 2015; 15(11):669-82. DOI: 10.1038/nri3902. View

20.

Quatromoni J, Eruslanov E . Tumor-associated macrophages: function, phenotype, and link to prognosis in human lung cancer. Am J Transl Res. 2012; 4(4):376-89. PMC: 3493031. View